GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Summary

The purpose of this study is to evaluate the prophylactic effects of Ganglioside-Monosialic Acid in post-chemotherapy cognitive impairment in patients with early operable breast cancer.

Timeline

Start

2022-02-08

Primary completion

2024-07-31

Completion

2024-07-31

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty accruing subjects the study accrual was closed”

Drugs

Indications